Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B, Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N, Büchler M, Pajic M, Biankin AV, Iovanna J, Neoptolemos J, Real FX.

    GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.

    GUT . : . Nº de citas: 227

    [doi:10.1136/gutjnl-2015-311256]

  • Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.

    Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae284]

  • Biesma NC, Graus MUJE, Cirkel GA, Besselink MG, de Groot JWB, Koerkamp BG, Herbschleb KH, Los M, Verdonk RC, Wilmink JW, Cervantes A, Valle JW, Valkenburg-van Iersel LBJ, Froeling FEM, Molenaar IQ, Daamen LA, de Vos-Geelen J, van Santvoort HC.

    Perspectives of the medical oncologist regarding adjuvant chemotherapy for pancreatic cancer: An international expert survey and case vignette study.

    EJSO . 51(3): 109544-109544. Nº de citas: 6

    [doi:10.1016/j.ejso.2024.109544]

  • Esparragosa Vázquez I, Fortes de la Torre I, Hilario A, Iglesias Lozano I, Hernández-Laín A, Pineda E, Sepúlveda Sánchez JM, Vaz-Salgado MA.

    Multidisciplinary consensus recommendations for the management of IDH-mutant grade 2 gliomas in Spain: a Delphi study.

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04338-0]

  • Adeva J, Carrato A, Macarulla T.

    Current patterns of next-generation sequencing testing in biliary tract cancer patients in Spain.

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04397-3]

  • Worthington C, Raitses-Gurevich M, Innamorati G, Hart PA, Wilkie TM, Tau N, Brin D, Yablecovitch D, Laish I, Keith D, Giles K, Permuth JB, Simeone DM, Zogopoulos G, Brand RE, Graff JJ, Earl J.

    Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.

    INTERNATIONAL JOURNAL OF CANCER . : .

    [doi:10.1002/ijc.70592]

  • Rodriguez Salas N, de la Haba-Rodriguez J, Ferragut Lloret F, Vaz Salgado MA, Oré Arce M, Cardeña Gutiérrez A, Beato Zambrano C, Rodríguez Alonso RM, López López R, García-Donas Jiménez J.

    SEOM-GETTHI clinical guideline for the practical management of molecular platforms (update 2026).

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04520-4]